Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,899 | 98,752 | 123,571 | 137,766 | 116,678 |
| Marketable Securities | 413 | 2,450 | N/A | N/A | N/A |
| Receivables | 229 | 188 | 207 | 390 | 901 |
| Other current assets | 2,007 | 2,019 | 14,589 | 13,418 | 12,803 |
| TOTAL | $94,989 | $110,523 | $144,035 | $160,828 | $136,359 |
| Non-Current Assets | |||||
| PPE Net | 3,089 | 3,563 | 4,227 | 5,286 | 6,338 |
| Investments And Advances | 3,206 | 3,206 | 3,206 | 3,206 | 3,206 |
| Intangibles | 622 | 388 | 375 | 386 | 400 |
| Other Non-Current Assets | 34,482 | 35,578 | 13,957 | 15,035 | 13,478 |
| TOTAL | $41,399 | $42,735 | $21,765 | $23,913 | $23,422 |
| Total Assets | $136,388 | $153,258 | $165,800 | $184,741 | $159,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,312 | 958 | 23,638 | 23,596 | 25,380 |
| Accrued Expenses | 7,198 | 6,885 | 4,350 | 1,876 | 6,535 |
| Other current liabilities | 989 | 1,385 | 1,916 | 2,772 | 2,391 |
| TOTAL | $14,980 | $11,982 | $32,957 | $33,338 | $49,987 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,321 | 22,278 | N/A | N/A | N/A |
| Deferred Revenues | 2,957 | 175 | 526 | 2,406 | 12,035 |
| Other Non-Current Liabilities | 19,394 | 27,550 | 31,346 | 39,431 | 17,851 |
| TOTAL | $65,015 | $76,410 | $58,129 | $114,197 | $90,933 |
| Total Liabilities | $79,995 | $88,392 | $91,086 | $147,535 | $140,920 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,482 | 7,671 | 7,234 | 6,926 | 6,916 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -482,464 | -464,719 | -448,294 | -481,043 | -489,631 |
| Other shareholders' equity | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $56,393 | $64,866 | $74,714 | $37,206 | $18,861 |
| Total Liabilities And Equity | $136,388 | $153,258 | $165,800 | $184,741 | $159,781 |